drugset

drugset / Trial / NCT01278693

Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients

NCT01278693 ↗

Phase 2 Completed 54 enrolled Isfahan University of Medical Sciences

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine Effect of oral L-carnitine supplement on lipid profile, anemia, and quality of life.

Timeline

Start: 2009-08
Primary completion: 2010-09
Completion: 2010-09

Publications

Nishioka N, Luo Y, Taniguchi T, Ohnishi T, Kimachi M, Ng RC, Watanabe N. Carnitine supplements for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev. 2022 Dec 6;12(12):CD013601. doi: 10.1002/14651858.CD013601.pub2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	L-carnitine	Other / unclassified	500 mg	Oral

Indications